Description

WHAT IS MDAI?

MDAI , 5,6-Methylenedioxy-2-aminoindane (commonly known as MDAI) is an entactogen substance of the aminoindane chemical class that produces entactogenic effects when administered. Notably, this compound primarily produces the non-stimulating effects of prototypical entactogens like MDMA such as sedation, muscle relaxation, and tactile enhancement.

Development

MDAI was developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a putatively non-neurotoxic and highly selective serotonin releasing agent (SSRA) with neglible effects on dopamine and norepinephrine. This reportedly limits its potential at producing overtly invigorating, prosocial or euphoric effects.

Market

MDAI has been marketed alongside research chemical entactogens like 5-MAPB, 5-APB, and 6-APB as a legal, grey-market alternative to MDMA.

Further information

Always consult your healthcare provider to ensure the information displayed here applies to your personal circumstances.

Additional information

Quantity

10g, 25g, 50g, 100g, 250g, 500g, 1000g

Reviews

There are no reviews yet.

Be the first to review “MDAI”

Your email address will not be published. Required fields are marked *